In hepatocellular carcinoma, ACSL4 upregulates the main lipogenic regulator SREBP1 through c-Myc, leading to the accumulation of intracellular triglycerides, cholesterol and lipid droplets, thereby promoting malignant tumor progression [28]. Here, MYC is linked to hepatocellular carcinoma.